Roszkowski, K., Zurawski, B., Jozwicki, W., Basta, P., & Lewandowska, M. A. (2014). Impact of Specific KRAS Mutation in Exon 2 on Clinical Outcome of Chemotherapy- and Radiotherapy-Treated Colorectal Adenocarcinoma Patients. Springer International Publishing.

Roszkowski, Krzysztof, Bogdan Zurawski, Wojciech Jozwicki, Pawel Basta, and Marzena Anna Lewandowska. Impact of Specific KRAS Mutation in Exon 2 On Clinical Outcome of Chemotherapy- and Radiotherapy-Treated Colorectal Adenocarcinoma Patients. Springer International Publishing, 2014.

Roszkowski, Krzysztof, et al. Impact of Specific KRAS Mutation in Exon 2 On Clinical Outcome of Chemotherapy- and Radiotherapy-Treated Colorectal Adenocarcinoma Patients. Springer International Publishing, 2014.